HilleVax, Inc. Profile Avatar - Palmy Investing

HilleVax, Inc.

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis c…

Biotechnology
US, Boston [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of HLVX's Analysis
CIK: 1888012 CUSIP: 43157M102 ISIN: US43157M1027 LEI: - UEI: -
Secondary Listings
HLVX has no secondary listings inside our databases.